Previous 10 | Next 10 |
2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...
2024-05-25 09:00:00 ET When looking to invest in dividend stocks, chasing high yields isn't always an advisable strategy. Companies with juicy yields are only worth investing in provided they can support their payouts. We saw just recently that even otherwise solid income stocks with incred...
2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...
2024-05-24 14:09:50 ET More on Cogent Biosciences Cogent downgraded at Baird on rare disease drug data Seeking Alpha’s Quant Rating on Cogent Biosciences Historical earnings data for Cogent Biosciences Financial information for Cogent Biosciences ...
2024-05-24 11:03:44 ET Summary The "Sell in May and go away" adage suggests selling stocks in May and returning in November, but historical data shows that June and July have been strong months. September is consistently the worst month for the stock market, with unpredictable ret...
2024-05-24 08:45:04 ET Palm Beach, FL – May 24, 2024 – The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic cancer, a particularly aggressive and often fatal form of ca...
2024-05-24 08:00:00 ET Summary Pfizer stock is at its lowest price in over 11 years, presenting a potential buying opportunity. The company's valuation is near historically low levels, and consensus analysts expect earnings to stabilize. The structure of price on the chart sug...
2024-05-24 05:05:00 ET Summary RGA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. In the first quarter, the macroeconomic env...
2024-05-23 16:47:14 ET Summary CureVac N.V. is developing an avian influenza [H5N1] vaccine with GSK plc; A phase 1 study is already underway to evaluate this vaccine. It is working on a seasonal influenza vaccine, but further optimization is needed to target influenza B; Dose-opt...
2024-05-23 14:20:37 ET More on BioNTech, Moderna, etc. Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Pfizer, Moderna in talks ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...